Exploring drug delivery for the DOT1L inhibitor pinometostat (EPZ-5676): Subcutaneous administration as an alternative to continuous IV infusion, in the pursuit of an epigenetic target

Exploring drug delivery for the DOT1L inhibitor pinometostat (EPZ-5676): Subcutaneous administration as an alternative to continuous IV infusion, in the pursuit of an epigenetic target

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Controlled Release - Volume 220, Part B, 28 December 2015, Pages 758-765

Nigel J. Waters, Scott R. Daigle, Bruce N. Rehlaender, Aravind Basavapathruni, Carly T. Campbell, Tyler B. Jensen, Brett F. Truitt, Edward J. Olhava, Roy M. Pollock, Kim A. Stickland, Angelos Dovletoglou,